iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Oppenheimer & Co. Inc.

Oppenheimer & Co. Inc. decreased its stake in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.9% during the second quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 35,426 shares of the financial services provider’s stock after selling 321 shares during the quarter. Oppenheimer & Co. Inc. owned about 0.07% of iShares Biotechnology ETF worth $4,863,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in IBB. Future Financial Wealth Managment LLC purchased a new stake in shares of iShares Biotechnology ETF in the 1st quarter valued at approximately $27,000. Bbjs Financial Advisors LLC acquired a new position in iShares Biotechnology ETF in the second quarter valued at approximately $31,000. Pacifica Partners Inc. grew its position in iShares Biotechnology ETF by 118.2% in the first quarter. Pacifica Partners Inc. now owns 240 shares of the financial services provider’s stock worth $33,000 after acquiring an additional 130 shares during the period. Crewe Advisors LLC increased its stake in iShares Biotechnology ETF by 42.9% during the fourth quarter. Crewe Advisors LLC now owns 260 shares of the financial services provider’s stock worth $35,000 after acquiring an additional 78 shares during the last quarter. Finally, YHB Investment Advisors Inc. acquired a new stake in iShares Biotechnology ETF during the first quarter worth $37,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 1.5 %

Shares of iShares Biotechnology ETF stock opened at $147.81 on Friday. iShares Biotechnology ETF has a 52 week low of $111.83 and a 52 week high of $150.17. The business’s fifty day simple moving average is $145.10 and its 200-day simple moving average is $138.28.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.